Knight Therapeutics (OTCMKTS:KHTRF) Trading 0.6% Higher – Still a Buy?

by · The Cerbat Gem

Knight Therapeutics Inc. (OTCMKTS:KHTRF – Get Free Report) shares rose 0.6% on Wednesday . The company traded as high as $4.3765 and last traded at $4.3765. Approximately 2,000 shares changed hands during mid-day trading, a decline of 34% from the average daily volume of 3,048 shares. The stock had previously closed at $4.35.

Knight Therapeutics Stock Up 0.6%

The company has a fifty day simple moving average of $4.30 and a 200-day simple moving average of $4.41.

About Knight Therapeutics

(Get Free Report)

Knight Therapeutics Inc (OTCMKTS:KHTRF) is a specialty pharmaceutical company headquartered in Montreal, Canada, focused on acquiring, in-licensing and commercializing innovative branded products for the Canadian and Latin American markets. The company secures exclusive marketing and distribution rights to medicines across multiple therapeutic areas, including ophthalmology, pain management, hematology and women’s health. Its portfolio features both prescription pharmaceuticals and specialty products that address unmet patient needs through targeted treatments.

Operating primarily in Canada, Mexico and select Latin American countries, Knight has established strategic alliances with global pharmaceutical firms to introduce novel therapies at various stages of development.

See Also